Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Net Income towards Common Stockholders: 2013-2025

Historic Net Income towards Common Stockholders for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $3.7 million.

  • Fortress Biotech's Net Income towards Common Stockholders rose 124.43% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.3 million, marking a year-over-year increase of 90.72%. This contributed to the annual value of -$55.9 million for FY2024, which is 18.61% up from last year.
  • Latest data reveals that Fortress Biotech reported Net Income towards Common Stockholders of $3.7 million as of Q3 2025, which was down 72.48% from $13.4 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Net Income towards Common Stockholders high stood at $13.4 million for Q2 2025, and its period low was -$62.4 million during Q4 2021.
  • In the last 3 years, Fortress Biotech's Net Income towards Common Stockholders had a median value of -$12.7 million in 2025 and averaged -$10.9 million.
  • In the last 5 years, Fortress Biotech's Net Income towards Common Stockholders plummeted by 159.68% in 2021 and then spiked by 200.12% in 2025.
  • Over the past 5 years, Fortress Biotech's Net Income towards Common Stockholders (Quarterly) stood at -$62.4 million in 2021, then surged by 53.64% to -$28.9 million in 2022, then soared by 60.95% to -$11.3 million in 2023, then climbed by 14.49% to -$9.7 million in 2024, then soared by 124.43% to $3.7 million in 2025.
  • Its Net Income towards Common Stockholders stands at $3.7 million for Q3 2025, versus $13.4 million for Q2 2025 and -$12.7 million for Q1 2025.